We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim results for the six months to 30 June 2013

8 Aug 2013 07:00

RNS Number : 2144L
Huntsworth PLC
08 August 2013
 



 

Huntsworth PLC

 

Interim results for the six months to 30 June 2013

 

Investment plan in place to stimulate top line growth

 

Huntsworth PLC, the global public relations and healthcare communications group, today announces its interim results for the six months to 30 June 2013.

 

Financial highlights1

 

Revenue

·; Revenue up 0.8% to £88.9m (H1 2012: £88.2m)

·; Like for like2 revenue decline of 0.5%

·; Investment plan in place to stimulate top line growth

·; Multi-office revenues up to 50% of Group revenues, with 2% like for like growth

·; Digital revenues up to 24% of Group revenues, with 9% like for like growth

·; Middle East and Asia Pacific like for like revenue growth at 7%

 

Profits before highlighted items

·; Operating profits of £12.4m (H1 2012: £13.7m)

·; Operating margin before central costs 17.9% (H1 2012: 20.5%)

·; Operating margin post central costs 14.0% (H1 2012: 15.5%)

·; Profit before tax of £10.6m (H1 2012: £11.6m)

 

Diluted earnings per share

·; Before highlighted items at 3.1p (H1 2012: 3.5p)

·; After highlighted items at 2.5p (H1 2012: 3.1p)

 

Cash flow and net debt

·; Cash flow from operating activities of £3.0m, representing a cash conversion of 24% (H1 2012: 57%)

·; Net debt at £69.0m (31 December 2012: £66.9m)

 

Dividend

·; Interim dividend of 1.0p (H1 2012: 1.0p)

BlueFocus investment

·; BlueFocus has received approval for the subscription from the National Development and Reform Commission (NDRC)

·; Its investment of £36.5m is expected to be completed in September 2013 subject to Huntsworth shareholder approval

 

 

Notes:

1) Unless otherwise stated, all results are adjusted to exclude highlighted items. Highlighted items comprise amortisation of intangible assets, restructuring costs, litigation costs and acquisition/transaction related costs/(credits).

2) Like for like revenues are stated at constant exchange rates and are adjusted to include pre-acquisition revenues and exclude disposals/closures.

Peter Chadlington, Chief Executive of Huntsworth, said:

 

"Citigate, Red and Huntsworth Health are all performing well. Grayling, under new leadership, is beginning to see the benefits of the investment plan announced in April to stimulate top line growth and capitalise on the growth of digital revenues. We believe that we are on track to meet full year management expectations.

 

We are working closely with BlueFocus in China and with its investment of £36.5m expected in September 2013 and just £9.6m of deferred contingent consideration payments remaining, the Group is set to deleverage significantly in the coming months."

 

 

 

Contacts:

 

Huntsworth PLC +44 (0)20 7224 8778

Peter Chadlington, Chief Executive

Sally Withey, Chief Operating Officer & Group Finance Director

 

Citigate Dewe Rogerson +44 (0)20 7638 9571

Simon Rigby

Jack Rich

Group Overview

In April 2013 we announced a strategic alliance and proposed £36.5m investment by BlueFocus, one of the leading PR and communication companies in China. The investment is subject to shareholder and regulatory approval. Huntsworth expects to send a circular to its shareholders during August 2013 and to convene a general meeting to approve and complete the subscription in September 2013.

In April we also announced an investment plan of £4m together with associated one-off restructuring costs of an additional £3m. The investments are focused on our key strategic areas of driving growth in digital revenues, expanding into new markets and attracting high calibre talent into our Group, and to ensure our networks are fit for purpose to deliver new revenues resulting from our BlueFocus alliance. The programme is already well underway, with £2m expenditure in the first half of the year, mainly on key investments across the Grayling network. The Group will hold a capital markets day in Beijing on October 23rd where we will present details of the resulting opportunities that we expect over the next three years.

Results for the first half are in line with our expectations. Revenues for the Group in the first six months of 2013 were £88.9m, up 0.8% from 2012, and operating profits were £12.4m after incurring first half investment plan expenditure of £2.0m. The underlying margin (excluding the impact of the investment plan) before central costs was 20.1%.

On a like for like basis, revenues declined by 0.5%, a result of strong growth in the USA and Rest of the World offset by continuing revenue declines in the UK and Europe.

Three of our four divisions are performing well. Huntsworth Health (which represents 33% of Group revenues) delivered strong like for like revenue growth of 9.7% and 13.6% profit growth, fuelled by 14% growth in digital revenues. Citigate (representing 14% of Group revenues) has seen an improved level of transaction activity in its flagship UK operations and saw revenues return to growth, having experienced declines due to the slow-down that followed last summer's Olympics. Red (representing 8% of Group revenues) has grown for 17 consecutive years, delivered flat revenue in the first half of 2013. This followed 11% growth in 2012.

Recessionary markets in the UK and Europe continued to affect Grayling, the Group's largest division which represents 45% of Group revenues.

Each of the key areas in which we are investing - digital, multi-office and expansion markets - performed well in the first six months and are showing good growth prospects across the Group.

·; Digital revenues now represent 24% of Group revenues, up 9%. Continued investment to roll out and strengthen these capabilities across our network presents a significant opportunity for growth.

·; Multi-office revenues grew by 2% on a like for like basis and now represent 50% of Group revenues. Now that we have brand recognition in this area, we are investing in talent to help win and grow these larger client accounts.

·; Unlike our larger competitors - particularly after the potential merger of Publicis and Omnicom - our growth markets are not just BRIC but also the USA where, with the addition of a US based CEO of our largest division, we are well placed to improve our market share significantly. Like for like revenues in our strategically important regions of Asia and the Middle East grew by 7% and our strategic alliance with BlueFocus will also be a key contributor to these growth areas.

These investment decisions will enable us to offset the impact of the headwinds created by the difficult economic conditions in Western Europe, which we believe could continue for a number of years.

 

Closing net debt was £69.0m. Debt levels remain comfortably within our facilities and covenants. With proceeds from the BlueFocus investment of £36.5m expected in September 2013, and just £9.6m of deferred contingent consideration payments remaining payable out to 2017, the Group is set to deleverage significantly in the coming months. On current forecasts and without further acquisitions we expect to be largely debt and earn-out free by 2017.

Cash conversion in the first half was relatively low at 24% as a result of certain expected receipts being delayed until July. Large clients are typically demanding longer billing cycles and credit terms, particularly in respect of some of our newer digital revenues. Notwithstanding this, we expect to improve our conversion rate to around 90% for the full year.

The interim dividend has been maintained at 1.0p, in line with the previous year.

Huntsworth Health

·; 33% of Group revenues

·; Operating margins of 21.1%

·; Like for like revenue growth of 9.7%

 

Huntsworth Health has delivered strong revenue growth of 9.7%. Digital revenues, representing 44% of the Division's revenues, grew 14% on a like for like basis. Multi-year agency-of-record assignments represent 76% of the Division's digital revenues. Multi-office revenues also continued to grow, up by 4.9%.

New business momentum is solid with unidentified new business under 4% of forecasted second half revenues. We have relocated staff to our Asia Regional Office in Singapore to build on our new alliance with BlueFocus and assist our clients who are looking for strong scientific expertise in the region.

Additionally Huntsworth Health has appointed new talent to build further growth platforms including a new social marketing agency based in New York.

Citigate

·; 14% of Group revenues

·; Operating margins of 20.7%

·; Like for like revenue growth of 0.4%

 

Following a quiet trading environment in 2012, transaction activity has improved in the first half of 2013, contributing to like for like revenue growth of 5.3% in Q2. We expect transaction activity to be sustained into Q3. The London office, which is the agency's flagship, has advised on two-market leading IPOs: Partnership Assurance, the biggest London IPO of 2013 by market value, and esure, the biggest London IPO by offer size. In addition, Citigate has advised on a number of high profile projects such as the London Stock Exchange Group's purchase of a controlling stake in LCH Clearnet. Corporate projects and retainers won include British Virgin Islands, Direct Line for Business, S&P Capital IQ and Aquila Capital.

Citigate offices around the network have also performed well. In France, Citigate has worked on M&A deals for Siraga, the gas cylinder manufacturer and designer, and Monceau Fleurs, the chain of florists. In Asia, Citigate advised on the Hong Kong IPO of Macau Legend Development and won a retained brief from China Construction Bank, the second largest bank in mainland China.

 

Red

·; 8% of Group revenues

·; Operating margins of 25.1%

·; Like for like revenue sustained at 2012 record levels

 

Red has delivered revenues consistent with H1 2012, which is a strong result on the back of 17 years of revenue growth and 16% like for like growth in the last two years. The agency continues to have a strong roster of FTSE 100 and Fortune 500 clients and should do well as the UK economy improves into 2014 and beyond.

The first half of 2013 saw the Division's new Nestle remit expand significantly and new assignments were won with Air France/KLM, Novo Nordisk and Ford Retail.

The Division also won nine industry awards in the first half across the consumer, technology and healthcare sectors.

Grayling

·; 45% of Group revenues

·; Operating margins of 13.5% (Underlying margin of 18.4% pre investments)

·; Like for like revenue decline of 7.2%

 

Economic turbulence in the UK and Europe, which accounts for 60% of Grayling's revenue, continued to impact the division's performance in the first half.

Grayling is continuing its transition from a business principally reliant on single office clients to one where the client base is increasingly multi-office or global. Grayling's brand and value recognition has strengthened but the expected decline in single office client revenues has been exacerbated by client budget reductions in the difficult markets in many of the areas where Grayling operates.

Following the arrival of the new CEO Pete Pedersen in March, management outlined a new plan and associated investment package. The plan is designed to stabilise the business, stem areas of revenue decline, address the lack of scale and market share in the US and Asia, build on the areas that are growing and promote longer-term revenue growth. Additionally, following the announcement of the Group's strategic alliance with BlueFocus, Grayling is ensuring the network is able to deliver the considerable opportunities that we think that relationship will bring.

The investment plan falls into three key categories: expansion of digital capabilities, multi-office expansion into new markets and investment in talent. The first half impact of the plan included:

1. Digital staff training programmes, investments in new technologies and key hires in digital talent, resulting in a strong pipeline of new business opportunities. While digital still requires significant expansion across the network early signs are encouraging with 1% like for like revenues growth.

2. A strengthening of the international delivery platform with an improved multi-office new business effort. Total wins in the four month period to 30 June were 5% ahead of the same period a year ago, with new wins and expansions including the following key clients; Hamad International Airport in Doha, Qatar, Qatar UK 2013 Year of Culture and Hilton Worldwide. This has resulted in our multi-office business growing 3% in the first half.

 

3. Recruitment of key talent and a restructured management will enhance Grayling's capabilities including:

·; In Asia, a Huntsworth regional CEO will join in January 2014, focusing initially on driving regional expansion of the Grayling network and leveraging the alliance with BlueFocus.

·; The first senior management secondment into BlueFocus is now underway and we have strengthened key management in the Middle East.

·; A Global Head of Social and Media Analytics has been appointed in Europe along with a San Francisco-based Head of Digital. Additionally a newly formed US Corporate Communications practice has been established in New York as well as a US-based Cyber Security practice.

As the investment plan continues to be implemented, Grayling starts the second half of the year with a solid foundation of network clients, an active pipeline of both digital and traditional work, new talent and executive leadership, and continued geographic expansion alongside BlueFocus.

The impact of the investment plan has diluted margins in the first half to 13.5%. We expect a similar margin in the second half of the year, but improvements into 2014 and beyond.

Group Outlook

We believe that we are on track to meet full year management expectations. We expect Huntsworth Health, Citigate and Red to continue to perform well. Grayling, which has been hampered by difficult economic conditions in many of the regions where it operates, has a significant investment plan underway to stimulate revenue growth and improve substantially its digital capabilities.

With the BlueFocus investment of £36.5m expected to be completed in September 2013 and just £9.6m of deferred contingent consideration payments remaining, the Group is expected to deleverage significantly in the coming months.

SUMMARY OF FINANCIAL RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2013

 

2013

Like for like growth

2012

£'m

%

£'m

Revenue

Citigate

12.1

0.4%

12.0

Grayling

40.4

(7.2)%

42.9

Huntsworth Health

29.5

9.7%

26.5

Red

6.9

0.0%

6.9

Eliminations

(0.0)

(0.1)

Total operations

88.9

(0.5)%

88.2

2013

Margin

2012

Margin

£'m

%

£'m

%

Operating profit

Citigate

2.5

20.7%

2.5

20.9%

Grayling

5.5

13.5%

8.7

20.2%

Huntsworth Health

6.2

21.1%

5.5

20.6%

Red

1.7

25.1%

1.4

21.1%

Total operations

15.9

17.9%

18.1

20.5%

Central costs

(3.5)

(4.4)

Operating profit before highlighted items

12.4

14.0%

13.7

15.5%

Highlighted items

(2.3)

(2.0)

Reported operating profit

10.1

11.4%

11.7

13.2%

Adjusted basic EPS

3.3p

3.7p

Reported basic EPS

2.6p

3.2p

 

 

Revenue and profits

Group revenue in the six months to 30 June 2013 increased by 0.8% to £88.9 million (H1 2012: £88.2 million).

On a like for like basis, revenues grew by 9.7% in Huntsworth Health, and 0.4% in Citigate. Revenues in Red were flat whilst Grayling saw a like for like revenue decline of 7.2%. Overall Group revenue declined by 0.5% on a like for like basis in the first half of the year.

Operating margins improved in Huntsworth Health and Red as compared to the first half of 2012, Citigate has remained consistent whereas margins in Grayling have declined as a result of our investment programme. Overall, Group operating profits before central costs in the first half declined by £2.2 million to £15.9 million, generating a Group operating margin before central costs of 17.9% (H1 2012: 20.5%).

The Group's operating margin after central costs decreased to 14.0% compared to 15.5% in in the first half of 2012.

 

Currency

The weakening of Sterling against the Euro and the Dollar has resulted in an £8.9 million credit to Other Comprehensive Income and Expense resulting from the retranslation of the Group's overseas assets. The impact on Group profits is £0.2 million.

Highlighted items

Highlighted items of £2.3 million in the first half of 2013 relate to the amortisation of intangible assets, restructuring costs and acquisition and transaction related credits/costs. (H1 2012: total operating highlighted items £2.0 million).

After highlighted items, statutory reported operating profit was £10.1 million (H1 2012: £11.7 million).

Tax

The total tax expense of £1.9 million comprises an adjusted tax expense of £2.5 million together with a credit of £0.6 million on highlighted items. The adjusted tax expense is based on the expected full year tax rate of 24.0% (year ended 31 December 2012: 23.0%).

Earnings

Profits attributable to ordinary shareholders before highlighted items were £8.1 million (H1 2012: £8.9 million). Adjusted basic earnings per share decreased to 3.3p (H1 2012: 3.7p) and adjusted diluted earnings per share decreased to 3.1p (H1 2012: 3.5p).

Profits after highlighted items attributable to ordinary shareholders were £6.4 million (H1 2012: £7.8 million), resulting in basic earnings per share of 2.6p (H1 2012: 3.2p) and diluted earnings per share of 2.5p (H1 2012: 3.1p).

Dividends

The interim dividend has been maintained at 1.0p per share (H1 2012: 1.0p). The record date for this dividend will be 4 October 2013 and it is payable on 8 November 2013. A scrip dividend alternative will be available.

Balance sheet and cash flow

Cash conversion of operating profit into operating cash flows in the first half was relatively low at 24% as a result of certain expected receipts being delayed until July. Large clients are typically demanding longer billing cycles and credit terms, particularly in respect of some of our newer digital revenues. Notwithstanding this, we expect to improve our conversion rate to around 90% for the full year. 

Cash inflow from operations totalled £3.0 million (H1 2012: £7.9 million), before highlighted cash outflows of £2.0 million. The other principal cash outflows during the period were net payments for interest, tax and fixed assets of £3.9 million.

Net debt at 30 June 2013 is £69.0 million (30 June 2012: £69.6 million; 31 December 2012 £66.9 million). Net debt remains well within the Group's available debt facilities. Financial covenants based on the Group's facility agreements continue to be comfortably met.

Earn-out obligations

Future earn-out obligations as at 30 June 2013 are estimated to be £9.6 million, comprising £4.1 million payable in cash and £5.5 million payable in cash or shares at Huntsworth's option. The expected timing of these obligations is £5.6 million in 2013 with the remaining £4.0 million payable between 2014 and 2017.

 

Key risks and uncertainties

As described more fully on pages 16 and 17 of the 2012 Annual Report and Accounts, the Group's key risks and uncertainties are identified as:

·; economic downturn - this can result in fewer new client mandates, longer procurement processes, pricing pressures and increased risk of bad debt;

·; increased industry competition - both from the number of competing agencies in the marketplace and price competition, impacting revenue and margins;

·; performance of acquired businesses - acquisitions may be less financially beneficial than anticipated;

·; dependence on key personnel - loss of key staff can impact client relationships and service quality;

·; loss of key clients - impacting revenue and profit;

·; information systems access and security - breaches could compromise operations;

·; country and currency risk - arising from the Group having significant operations in the United States of America and Europe;

·; loan facility and covenant headroom risk - resulting in reputational damage and/or impairing ability to make future acquisitions or settle existing obligations;

·; working capital risk - increased levels of working capital can have a cash cost to the Group;

·; legal and regulatory compliance - potentially giving rise to reputational and/or financial damage; and

·; unethical business practices - potentially leading to reputational and/or financial damage.

The Group performs a comprehensive annual risk assessment exercise involving all senior management teams around the Group to identify, report and evaluate operational risks facing the business and ensure appropriate actions are undertaken to manage these risks.

The Directors have considered whether these risks have changed since the 2012 Annual Report and Accounts were published and in particular whether the Group's exposure to country and currency risk has changed in light of the continued economic uncertainty in certain countries. Geographically, 36% of Group revenue in the first half of 2013 was from the UK and 20% from other European countries. The Group's risk in these locations is mitigated by continued monitoring of business wins and losses, staffing levels and aged debts. The Directors do not consider that the level of risk that the Group is exposed to has increased significantly in the first half of 2013.

Forward looking statements

The interim management report contains certain forward looking statements in respect of Huntsworth plc and the operation of its subsidiaries. These statements and forecasts involve risk and uncertainty because they relate to events and depend upon circumstances that may or may not occur in the future. There are a number of factors that could cause actual results or developments to differ materially from those expressed or implied by these forward looking statements and forecasts. Nothing in this announcement should be construed as a profit forecast.

 

Notes to Editors:

 

1. Huntsworth PLC is a global public relations and healthcare communications group with 73 principal offices across 28 countries. In the first half of 2013 the Group worked for circa 1,770 clients.

2. The Group comprises four divisions: Grayling, Citigate, Red and Huntsworth Health. At 30 June 2013 the Group employed approximately 1,700 staff with an average annual fee income per head of £105,000.

3. By industry sector the revenue profile is broadly 19% Pharmaceuticals; 11% Technology; 15% Healthcare; 10% Financial Services; 9% Retail & Leisure; 6% Government & Public Sector; 5% Food and Drink, 5% Professional Services, 4% Industrial and 16% Other sectors.

4. Geographically, 36% of Group revenue in the first half of 2013 was from the UK; 20% from other European countries; 38% from the US; and 6% from the Rest of the World.

5. The Group's global and multi-office clients represent 50% of revenue.

6. Over 41% of the Group's revenue is derived from companies in the FTSE 100, Fortune 500, FTSEurofirst 300 or Top 50 Pharma Companies.

7. Each of the Group's top 14 clients already have annual committed revenue in excess of £1 million. In the first half of 2013 our largest client represents 3% of revenue with the top 10 clients accounting for 21% and the top 25 clients accounting for 34%.

 

 

 

 

 

 

Audited

 

 

 

Six months

Six months

Year

 

 

 

ended

ended

ended

 

 

 

30 June

30 June

31 December

 

 

 

2013

2012

2012

 

 

Notes

£000

£000

£000

Turnover

 

106,619

107,055

215,526

 

 

 

 

 

Revenue

2

88,890

88,205

173,030

Operating expenses - excluding highlighted items

 

(76,442)

(74,522)

(146,483)

Operating expenses - highlighted items

3

(2,329)

(2,021)

(3,613)

Operating expenses - total

 

(78,771)

(76,543)

(150,096)

Operating profit before highlighted items

2

12,448

13,683

26,547

Highlighted items - operating expenses

3

(2,329)

(2,021)

(3,613)

Operating profit

 

10,119

11,662

22,934

Finance income

4

2

6

13

Finance costs

4

(1,809)

(2,116)

(4,102)

Profit before tax and highlighted items

 

10,641

11,573

22,458

Highlighted items

3

(2,329)

(2,021)

(3,613)

Profit before tax

 

8,312

9,552

18,845

Taxation expense

5

(1,934)

(1,745)

(3,522)

Profit for the period

 

6,378

7,807

15,323

 

 

 

 

 

Attributable to:

 

 

 

 

Parent Company's equity shareholders

 

6,378

7,807

15,323

 

Earnings per share:

 

 

 

 

Basic - pence

7

2.6

3.2

6.3

Diluted - pence

7

2.5

3.1

6.1

Adjusted basic - pence*

7

3.3

3.7

7.1

Adjusted diluted - pence*

7

3.1

3.5

6.9

*Adjusted basic and diluted earnings per share are calculated based on the profit for the period adjusted for highlighted items and the related tax effects (Note 7).

 

 

 

Six months

 ended

 

Six months

 ended

Audited

Year

 ended

 

30 June

30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Profit for the period

6,378

7,807

15,323

 

 

 

 

Other comprehensive income and expense

 

 

 

Items that may be reclassified subsequently to the income statement

 

 

 

Amounts recognised in the Income Statement on interest rate swaps

137

353

487

Movement in valuation of interest rate swaps

3

(39)

(43)

Tax expense on interest rate swaps

(32)

(77)

(118)

Currency translation movement

8,879

(2,185)

(5,841)

Tax credit/(expense) on currency translation differences

7

(69)

3

Total items that may be reclassified subsequently to profit or loss

8,994

(2,017)

(5,512)

Other comprehensive income and expense for the period

8,994

(2,017)

(5,512)

 

 

 

 

Total comprehensive income and expense for the period

15,372

5,790

9,811

 

 

 

 

Total comprehensive income and expense attributable to:

 

 

 

Parent Company's equity shareholders

15,372

5,790

9,811

 

 

 

 

Audited

 

 

30 June

30 June

31 December

 

 

2013

2012

2012

 

Notes

£000

£000

£000

Non-current assets

 

 

 

 

Intangible assets

8

302,779

298,316

293,628

Property, plant and equipment

 

5,433

5,475

5,430

Other receivables

 

228

161

279

Deferred tax assets

 

106

122

92

 

 

308,546

304,074

299,429

Current assets

 

 

 

 

Work in progress

 

4,904

4,022

4,041

Trade and other receivables

 

53,487

46,862

43,049

Current tax receivable

 

430

538

190

Derivative financial assets

9

-

61

72

Cash and short-term deposits

 

4,864

5,178

4,677

 

 

63,685

56,661

52,029

Current liabilities

 

 

 

 

Bank loans and overdrafts

10,12

(6,102)

(3,095)

(6,010)

Obligations under finance leases

 

(7)

(10)

(10)

Trade and other payables

 

(54,099)

(51,867)

(48,089)

Derivative financial liabilities

9

(21)

(269)

-

Current tax payable

 

(1,702)

(2,657)

(1,967)

Provisions

11

(6,922)

(6,469)

(6,502)

 

 

(68,853)

(64,367)

(62,578)

Non-current liabilities

 

 

 

 

Bank loans and overdrafts

10

(67,472)

(71,160)

(65,156)

Obligations under finance leases

 

(2)

(8)

(3)

Trade and other payables

 

(1,018)

(1,109)

(1,014)

Derivative financial liabilities

9

(293)

(292)

(433)

Deferred tax liabilities

 

(4,063)

(1,687)

(2,515)

Provisions

11

(5,209)

(11,812)

(5,602)

 

 

(78,057)

(86,068)

(74,723)

Net assets

 

225,321

210,300

214,157

Equity

 

 

 

 

Called up share capital

 

106,465

106,385

106,444

Share premium account

 

26,936

26,594

26,942

Merger reserve

 

63,136

64,375

61,966

Foreign currency translation reserve

 

27,938

22,715

19,059

Hedging reserve

 

(229)

(499)

(369)

Treasury shares

 

(1,577)

(2,144)

(2,153)

Investment in own shares

 

(4,775)

(5,102)

(4,775)

Retained earnings

 

7,427

(2,024)

7,043

Equity attributable to equity holders of the parent

 

225,321

210,300

214,157

 

 

 

 

 

Audited

 

 

Six months

Six months

Year

 

 

ended

 ended

ended

 

 

30 June

30 June

31 December

 

 

2013

2012

2012

 

Notes

£000

£000

£000

Cash(outflow)/inflow from operating activities

 

 

 

 

Cash inflow from operations

12(a)

982

5,315

23,080

Interest paid

 

(1,537)

(2,087)

(3,791)

Interest received

 

2

6

12

Cash flows from hedging activities

 

72

(43)

(42)

Net current tax paid

 

(1,333)

(919)

(2,212)

Net cash (outflow)/inflow from operating activities

 

(1,814)

2,272

17,047

Cash outflow from investing activities

 

 

 

 

Acquisition of subsidiaries, net of cash acquired, and deferred consideration payments

 

-

-

(2,607)

Cost of internally developed intangible assets

 

(66)

(43)

(138)

Purchases of property, plant and equipment

 

(1,004)

(739)

(1,884)

Proceeds from sale of property, plant and equipment

 

-

6

43

Net cash outflow from investing activities

 

(1,070)

(776)

(4,586)

Cash inflow/(outflow) from financing activities

 

 

 

 

Purchase of own shares - treasury shares

 

-

(4)

(13)

Proceeds from sale of own shares to settle share options

 

346

-

105

Repayment of finance lease liabilities

 

(5)

(19)

(24)

Net drawdown/(repayment) of borrowings

 

2,059

(1,805)

(5,028)

Dividends paid to equity holders of the parent

 

-

-

(8,034)

Net cash inflow/(outflow) from financing activities

 

2,400

(1,828)

(12,994)

Decrease in cash and cash equivalents

 

(484)

(332)

(533)

Movements in cash and cash equivalents

 

 

 

 

Decrease in cash and cash equivalents

 

(484)

(332)

(533)

Effects of exchange rate fluctuations on cash held

 

579

(146)

(361)

Cash and cash equivalents at 1 January

 

4,667

5,561

5,561

Cash and cash equivalents at end of period

12 (d)

4,762

5,083

4,667

Called

Foreign

up

Share

currency

Investment

share

premium

Merger

translation

Hedging

Treasury

in own

Retained

Total

capital

account

reserve

reserve

reserve

shares

shares

earnings

Equity

£000

£000

£000

£000

£000

£000

£000

£000

£000

At 1 January 2012

106,385

26,594

64,375

24,900

(813)

(2,140)

(5,338)

(3,868)

210,095

Profit for the period

-

-

-

-

-

-

-

7,807

7,807

Other comprehensive income/(expense)

-

-

-

(2,185)

314

-

-

(146)

(2,017)

Total comprehensive income

-

-

-

(2,185)

314

-

-

7,661

5,790

Purchase of own shares

-

-

-

-

-

(4)

-

-

(4)

Settlement of share options

-

-

-

-

-

-

236

(236)

-

Credit for share-based payments

-

-

-

-

-

-

-

247

247

Tax on share based payments

-

-

-

-

-

-

-

135

135

Equity dividends

-

-

-

-

-

-

-

(5,963)

(5,963)

At 30 June 2012

106,385

26,594

64,375

22,715

(499)

(2,144)

(5,102)

(2,024)

210,300

Profit for the period

-

-

-

-

-

-

-

7,516

7,516

Other comprehensive income/(expense)

-

-

-

(3,656)

130

-

-

31

(3,495)

Total comprehensive income

-

-

-

(3,656)

130

-

-

7,547

4,021

Acquisitions of subsidiaries

50

-

2,186

-

-

-

-

-

2,236

Purchase of own shares

-

-

-

-

-

(9)

-

-

(9)

Settlement of share options

-

-

-

-

-

-

327

(222)

105

Charge for share-based payments

-

-

-

-

-

-

-

(346)

(346)

Tax on share based payments

-

-

-

-

-

-

-

(64)

(64)

Share issue costs

-

(16)

-

-

-

-

-

-

(16)

Scrip dividends

9

364

-

-

-

-

-

-

373

Equity dividends

-

-

-

-

-

-

-

(2,443)

(2,443)

Transfers

-

-

(4,595)

-

-

-

-

4,595

-

At 31 December 2012 (audited)

106,444

26,942

61,966

19,059

(369)

(2,153)

(4,775)

7,043

214,157

Profit for the period

-

-

-

-

-

-

-

6,378

6,378

Other comprehensive income/(expense)

-

-

-

8,879

140

-

-

(25)

8,994

Total comprehensive income

-

-

-

8,879

140

-

-

6,353

15,372

Acquisitions of subsidiaries

21

-

1,170

-

-

-

-

-

1,191

Settlement of share options

-

-

-

-

-

576

-

(233)

343

Credit for share-based payments

-

-

-

-

-

-

-

230

230

Tax on share-based payments

-

-

-

-

-

-

-

174

174

Share issue costs

-

(6)

-

-

-

-

-

-

(6)

Equity dividends

-

-

-

-

-

-

-

(6,140)

(6,140)

At 30 June 2013

106,465

26,936

63,136

27,938

(229)

(1,577)

(4,775)

7,427

225,321

 

1. Basis of preparation

The condensed consolidated interim financial statements for the six months ended 30 June 2013 have been prepared in accordance with the Disclosure and Transparency Rules of the Financial Conduct Authority, IAS 34 "Interim Financial Reporting" and the Group's accounting policies.

The Group's accounting policies are in accordance with International Financial Reporting Standards as adopted by the European Union and are set out in the Group's Annual Report and Accounts 2012 on pages 52-56, except as noted below. These are consistent with the accounting policies which the Group expects to adopt in its 2013 Annual Report. The Group has not early adopted any Standard, Interpretation or Amendment that has been issued but is not yet effective.

The information relating to the six months ended 30 June 2013 and 30 June 2012 is unaudited and does not constitute statutory financial statements as defined in Section 434 of the Companies Act 2006. The information has however been reviewed by the auditors and their report to the Board of Huntsworth plc is set out on page 28 of this document. The comparative figures for the year ended 31 December 2012 have been extracted from the Group's Annual Report and Accounts 2012, on which the auditors gave an unmodified opinion and did not include a statement under section 498 (2) or (3) of the Companies Act 2006. The Group Annual Report and Accounts for the year ended 31 December 2012 have been filed with the Registrar of Companies.

 

Changes in accounting policies

The following new standards and amendments to standards are mandatory for the first time for the financial year beginning 1 January 2013:

 

·; IFRS 13 Fair Value Measurement. IFRS 13 measurement and disclosure requirements are applicable for the December 2013 year end. The group has included the disclosures required by IAS 34.

 

The following new standards, amendments to standards and interpretations were also mandatory for the first time for the financial year beginning 1 January 2013, but had no significant impact on the Group:

 

·; IAS 1 (amendment) - Presentation of Items in Other Comprehensive Income (effective for accounting periods beginning on or after 1 July 2012);

·; IAS 19 (amendment) Employee Benefits (effective for accounting periods beginning on or after 1 January 2013);

·; IFRS 1 (amendment) Government Loans (effective for accounting periods beginning on or after 1 January 2013);

·; IFRIC 20 Stripping costs in the Production Phase of a Surface Mine (effective for accounting periods beginning on or after 1 January 2013);

·; IFRS 7 (amendment) Financial Instruments: Disclosures - Offsetting Financial Assets and Financial Liabilities (effective for accounting periods beginning on or after 1 January 2013);

 

Going concern

After reviewing the Group's performance, future forecasted performance and cash flows, and ability to draw down on its facilities and the covenant requirements of those facilities, and after considering the key risks and uncertainties set out on page 9, the Directors consider that the Group has sufficient resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the Group's financial statements.

 

2. Segmental analysis

The following is an analysis of the Group's revenue and operating profit before highlighted items by reportable segment.

 

Citigate

Grayling

Red

Huntsworth Health

Total

6 months to 30 June 2013

£000

£000

£000

£000

£000

Revenue

Total revenue

12,141

40,437

6,880

29,448

88,906

Intra-group eliminations

-

(16)

-

-

(16)

Segment revenue

12,141

40,421

6,880

29,448

88,890

Segment operating profit before highlighted items

2,514

5,469

1,726

6,203

15,912

 

Citigate

Grayling

Red

Huntsworth Health

Total

6 months to 30 June 2012

£000

£000

£000

£000

£000

Revenue

Total revenue

11,980

42,944

6,879

26,505

88,308

Intra-group eliminations

(41)

(62)

-

-

(103)

Segment revenue

11,939

42,882

6,879

26,505

88,205

Segment operating profit before highlighted items

2,507

8,662

1,451

5,462

18,082

 

 

2. Segmental analysis continued

 

Citigate

Grayling

Red

Huntsworth Health

Total

Year ended 31 December 2012

£000

£000

£000

£000

£000

Revenue

Total revenue

22,767

83,546

13,878

52,953

173,144

Intra-group eliminations

(3)

(110)

-

(1)

(114)

Segment revenue

22,764

83,436

13,878

52,952

173,030

Segment operating profit before highlighted items

4,191

15,317

2,605

11,462

33,575

 

 

A reconciliation of segment operating profit before highlighted items to profit before tax is provided below:

 

 

Six months

Six months

Year

ended

ended

ended

30 June

30 June

31 December

2013

 2012

2012

£000

£000

£000

Segment operating profit before highlighted items

15,912

18,082

33,575

Unallocated costs

(3,464)

(4,399)

(7,028)

Operating profit before highlighted items

12,448

13,683

26,547

Highlighted items

(2,329)

(2,021)

(3,613)

Operating profit

10,119

11,662

22,934

Net finance costs

(1,807)

(2,110)

(4,089)

Profit before tax

8,312

9,552

18,845

 

 

 

3. Highlighted items

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Charged to operating profit

 

 

 

Amortisation of intangible assets

813

2,151

3,924

Restructuring costs

2,203

615

840

Litigation costs

-

10

156

Acquisition and transaction related credit

(687)

(755)

(1,307)

Charged to profit before tax

2,329

2,021

3,613

Taxation credit

(619)

(919)

(1,639)

Charged to profit for the year

1,710

1,102

1,974

 

Highlighted items charged to profit before tax comprise significant non-cash charges and non-recurring items which are highlighted in the Income Statement because, in the opinion of the Directors, separate disclosure is helpful in understanding the underlying performance of the business.

 

Amortisation of intangible assets

Intangible assets are amortised systematically over their estimated useful lives, which vary from 2 to 20 years depending on the nature of the asset. These are significant non-cash charges which arise as a result of acquisitions.

 

Restructuring costs

Restructuring costs include severance payments, property and other contract termination costs.

 

Litigation costs

Litigation costs relate to legal and settlement costs.

 

Acquisition and transaction related credit

In line with the requirements of IFRS 3 (revised) 'Business Combinations', costs incurred in relation to acquisitions and any adjustments to the fair value of deferred contingent consideration liabilities are taken to the Income Statement rather than being included as part of the cost of investment or as an adjustment to goodwill. The balance in 2013 relates to the revaluation credit of deferred contingent consideration of £0.8 million (refer to Note 11) and an expense of £0.1 million relating to transaction costs incurred in respect of the proposed BlueFocus transaction, announced in April 2013. In 2012, the credit was wholly in respect of adjustments to deferred contingent consideration liabilities.

 

Taxation

The taxation credit relates to the tax impact of the above highlighted items.

 

 

4. Finance costs and income

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Bank interest payable

1,785

2,083

4,039

Finance lease interest

4

4

9

Imputed interest on property and other provisions

4

8

12

Imputed interest on deferred consideration

16

21

42

Finance costs

1,809

2,116

4,102

Bank interest receivable

-

(2)

(8)

Other interest receivable

(2)

(4)

(5)

Finance income

(2)

(6)

(13)

Net finance costs

1,807

2,110

4,089

 

5. Taxation

The tax expense/(credit) for the six months ended 30 June 2013 has been based on an estimated effective tax rate on profit before tax and highlighted items for the full year of 24.0% (year ended 31 December 2012: 23.0%). The tax expense/(credit) is analysed as follows:

 

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Before highlighted items:

 

 

 

Current tax

1,357

1,392

2,422

Deferred tax

1,196

1,272

2,739

 

2,553

2,664

5,161

Highlighted items:

 

 

 

Current tax

(443)

(366)

(319)

Deferred tax

(176)

(553)

(1,320)

 

(619)

(919)

(1,639)

Total:

 

 

 

Current tax

914

1,026

2,103

Deferred tax

1,020

719

1,419

Total tax expense

1,934

1,745

3,522

 

The UK's Finance Act 2013 introduced legislation to reduce the main rate of corporation tax from 23% to 21% from 1 April 2014. However as this change was only substantively enacted on 2 July 2013 following the current reporting date, the Group's deferred tax balances have not been updated to reflect this change. The deferred tax balances in the Group's full year results to 31 December 2013 will incorporate this change in tax rate although it is not considered that this will have a significant impact on the Group's full year effective tax rate.

 

 

 

6. Dividends

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Equity dividends on ordinary shares:

 

 

 

Final dividend for the year ended 2011 - 2.50 pence

-

5,693

5,963

Interim dividend for the year ended 2012 - 1.0 pence

-

-

2,443

Final dividend for the year ended 2012 - 2.50 pence

6,140

-

-

 

6,140

5,693

8,406

 

The final dividend for the year ended 31 December 2012 of 2.50 pence per share was approved by shareholders at the Annual General Meeting on 13 June 2013 and was paid on 5 July 2013. This dividend is included in trade and other payables at 30 June 2013.

 

The proposed 2013 interim dividend of 1.0 pence per share was approved by the Board on 7 August 2013. The dividend will be paid on 8 November 2013 to those shareholders on the register on 4 October 2013.

 

7. Earnings per share

The data used in the calculation of the earnings per share numbers is summarised in the table below:

 

 

Six months ended

Six months ended

Year ended

 

30 June 2013

30 June 2012

31 December 2012

 

Weighted

Weighted

Weighted

 

average number

average number

average number

 

Earnings

£000

of shares

000's

Earnings

£000

of shares

000's

Earnings

£000

of shares

000's

Basic

6,378

247,927

7,807

241,220

15,323

243,585

Diluted

6,378

259,049

7,807

251,893

15,323

251,674

Adjusted basic

8,088

247,927

8,909

241,220

17,297

243,585

Adjusted diluted

8,088

259,049

8,909

251,893

17,297

251,674

 

The basic earnings per share calculation is based on the profit for the period attributable to parent company shareholders divided by the weighted average number of ordinary shares outstanding during the period.

 

Diluted earnings per share is calculated based on the profit for the period attributable to parent company shareholders divided by the weighted average number of ordinary shares outstanding during the period adjusted for the potentially dilutive impact of employee share option schemes and shares to be issued as part of contingent consideration on acquisition of subsidiaries.

 

 

 

7. Earnings per share continued

Adjusted earnings per share is calculated in order to provide information to shareholders about continuing trading performance and is based on the profit attributable to parent company shareholders excluding highlighted items together with related tax effects as set out below:

 

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Earnings:

 

 

 

Profit for the period attributable to the Parent Company's shareholders

6,378

7,807

15,323

Highlighted items (net of tax) attributable to the Parent Company's shareholders

1,710

1,102

1,974

Adjusted earnings

8,088

8,909

17,297

 

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Number of shares:

 

 

 

Weighted average number of ordinary shares -

basic and adjusted basic

247,927

241,220

243,585

Effect of share options in issue

5,605

5,652

6,937

Effect of deferred contingent consideration

5,517

5,021

1,152

Weighted average number of ordinary shares - diluted and adjusted diluted

259,049

251,893

251,674

 

 

 

8. Intangible assets

 

Brands

Customer relationships

Goodwill

Intellectual property

Software develop-

ment costs

Total

 

£000

£000

£000

£000

£000

£000

Cost

 

 

 

 

 

 

At 1 January 2013

24,874

29,298

303,070

1,699

951

359,892

Adjustments to prior year acquisitions

-

-

1,132

-

-

1,132

Capitalised development costs

-

-

-

-

66

66

Foreign exchange movement

803

1,270

9,388

77

44

11,582

At 30 June 2013

25,677

30,568

313,590

1,776

1,061

372,672

Amortisation

 

 

 

At 1 January 2013

19,118

28,539

17,379

595

633

66,264

Charge for the period

244

392

-

176

81

893

Foreign exchange movement

748

1,230

706

30

22

2,736

At 30 June 2013

20,110

30,161

18,085

801

736

69,893

Net book value at 30 June 2013

5,567

407

295,505

975

325

302,779

Net book value at 31 December 2012

5,756

759

285,691

1,104

318

293,628

Net book value at 30 June 2012

6,006

2,160

288,517

1,256

377

298,316

 

Adjustments to goodwill on prior year acquisitions represent changes to contingent deferred consideration payable. This adjustment is made for acquisitions completed prior to 1 January 2010. Adjustments to deferred consideration payable for acquisitions completed after this date are taken to the Income Statement as highlighted items.

 

The Directors have reassessed the carrying value of intangible assets and are satisfied that no impairment is required as at 30 June 2013.

 

9. Financial risk management and financial instruments

The group's activities expose it to a variety of financial risks including foreign exchange risk, interest rate risk, credit risk and liquidity risk.

 

The condensed interim financial statements do not include all financial risk management information and disclosures required in the annual financial statements; they should be read in conjunction with the Group's Annual Financial Statements as at 31 December 2012. There have been no changes in the Group's risk management policies since the year end.

 

Fair value measurement

The following table provides an analysis of financial instruments that are measured subsequent to initial recognition at fair value, grouped into Levels 1 to 3 based on the degree to which the fair value is observable.

·; Level 1 fair value measurements are those derived from quoted prices (unadjusted) in active markets for identical assets or liabilities.

·; Level 2 fair value measurements are those derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices).

·; Level 3 fair value measurements are those derived from valuation techniques that include inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

 

9. Financial risk management and financial instruments continued

 

Fair value measurement continued

 

At 30 June 2013

Level 1

£000

Level 2

£000

Level 3

£000

Total

£000

Financial liabilities 

Interest rate swaps

-

293

-

293

Foreign exchange cylinder

-

21

-

21

Deferred contingent consideration (Note 11)

-

-

9,649

9,649

-

314

9,649

9,963

 

 

At 31 December 2012

Level 1

£000

Level 2

£000

Level 3

£000

Total

£000

Financial assets 

Average rate foreign currency contract

-

72

-

72

-

72

-

72

Financial liabilities 

Interest rate swaps

-

433

-

433

Deferred contingent consideration (Note 11)

-

-

10,110

10,110

-

433

10,110

10,543

 

Valuation techniques used to derive Level 2 fair values

Level 2 derivatives comprise foreign exchange contracts and interest rate swaps. The foreign exchange contracts have been fair valued using exchange rates that are quoted in an active market. Interest rate swaps are fair valued using forward interest rates extracted from observable yield curves.

 

Fair values of other financial liabilities and assets

All financial assets and financial liabilities have been recognised at their carrying values which are not materially different to their fair values.

 

10. Bank loans and overdrafts

The Group has a £102 million (year ended 31 December 2012: £105 million) multi-currency facility with Lloyds TSB Bank plc, The Royal Bank of Scotland plc and Clydesdale Bank plc and a £5 million committed overdraft facility with Lloyds TSB Bank plc. During the period, the multi-currency facility reduced by £3 million in accordance with the terms and conditions of the agreement. Both facilities are due to expire in May 2015. The margin payable on the facility is variable between 1.75% and 2.90% depending on the Group's net debt to EBITDA ratio.

 

 

 

11. Provisions

 

Deferred contingent consideration

Property

Reorganisation

and other

Total

£000

£000

£000

£000

At 31 December 2012

10,110

1,718

276

12,104

Arising during the year

1,132

282

927

2,341

Released during the year

(770)

(135)

-

(905)

Foreign exchange movement

352

27

18

397

Utilised

(1,191)

(94)

(541)

(1,826)

Unwind of discount

16

4

-

20

At 30 June 2013

9,649

1,802

680

12,131

Current

5,671

571

680

6,922

Non-current

3,978

1,231

-

5,209

 

Deferred contingent consideration for acquisitions

Acquisitions made by the Group typically involve an earn-out arrangement whereby the consideration payable includes a deferred element, payable in either cash or a combination of cash and shares at the Company's option, that is contingent on the future financial performance of the acquired entity. The Group anticipates settling the deferred consideration provisions over the next four years. The amount arising/(released) in the period represents the change in the estimated earn-out based on the latest financial performance of the acquired businesses. The potential undiscounted amount of future payments that could be required under all outstanding earnout arrangements ranges from £nil to £33.7 million.

 

Property provisions

Provisions for property represent amounts set aside in respect of property leases which are onerous and the unavoidable costs of restoring leasehold properties to the condition specified in the lease at the end of the contractual term. The quantification of these provisions has been determined based on external professional advice and is dependent on the Group's timing of exiting the leases or to sublet the properties. In general, property provisions are expected to be utilised over a range of one to five years.

 

Reorganisation and other provisions

This provision relates principally to employee termination benefits. In addition, when acquiring businesses, provisions have been made to cover the best estimate of the Group's exposure to liabilities arising due to the acquisition.

 

 

12. Cash flow analysis

(a) Reconciliation of operating profit to net cash inflow from operations

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

 30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Operating profit

10,119

11,662

22,934

Depreciation

1,226

1,175

2,212

Share option charge/(credit)

230

247

(99)

Loss on disposal of property, plant and equipment

2

10

8

Amortisation of intangible assets

893

2,219

4,086

Unrealised foreign exchange loss/(gain) on hedging instrument

21

(18)

(30)

(Increase)/decrease in work in progress

(835)

28

9

Increase in debtors

(7,247)

(4,452)

(2,653)

(Decrease)/increase in creditors

(3,084)

(3,190)

442

Increase in provisions

(343)

(2,366)

(3,829)

Net cash inflow from operations

982

5,315

23,080

 

 

Net cash inflow from operations is analysed as follows:

 

Six months

Six months

Year

 

ended

ended

ended

 

30 June

 30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Before highlighted items

2,979

7,865

26,859

Highlighted items

(1,997)

(2,550)

(3,779)

Net cash inflow from operations

982

5,315

23,080

 

 (b) Reconciliation of net cash flow to movement in net debt

 

Six months

Six months

Year

 

ended

ended

 ended

 

 30 June

 30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Decrease in cash and cash equivalents in the period

(484)

(332)

(533)

Cash (inflow)/outflow from debt drawdowns

(2,059)

1,805

5,028

Repayment of capital element of finance leases

5

19

24

Change in net debt resulting from cash flows

(2,538)

1,492

4,519

Amortisation of loan fees

(258)

(219)

(439)

Movement in fair value of derivative financial instruments

47

377

516

Translation differences

579

(146)

(360)

(Increase)/decrease in net debt

(2,170)

1,504

4,236

Net debt at beginning of period

(66,863)

(71,099)

(71,099)

Net debt at end of period

(69,033)

(69,595)

(66,863)

 

 

 

 

12. Cash flow analysis (continued)

 (c) Analysis of net debt

 

30 June

30 June

31 December

 

2013

2012

2012

 

£000

£000

£000

Cash and short-term deposits

4,864

5,178

4,677

Overdrafts (current)

(102)

(95)

(10)

Net cash and cash equivalents

4,762

5,083

4,667

Bank loans (current)

(6,000)

(3,000)

(6,000)

Bank loans and overdrafts (non-current)

(67,472)

(71,160)

(65,156)

Derivative financial assets

-

61

72

Derivative financial liabilities

(314)

(561)

(433)

Obligations under finance leases

(9)

(18)

(13)

Net debt

(69,033)

(69,595)

(66,863)

 

(d) Cash and cash equivalents

 

 

 

 

 

30 June

 30 June

 31 December

 

2013

2012

2012

 

£000

£000

£000

Cash and short-term deposits

4,864

5,178

4,677

Overdrafts (current)

(102)

(95)

(10)

Cash and cash equivalents

4,762

5,083

4,667

 

13. Related party transactions

The ultimate controlling party of the Group is Huntsworth plc (incorporated in the United Kingdom). The Group has a related party relationship with Directors and executive officers. There were no material related party transactions other than the remuneration of key management personnel of £903,000 in the six months ended 30 June 2013 (2012: £1,028,000).

 

 

 

 

14. Contingent liabilities

As a result of the proposed BlueFocus investment, the group is expecting to incur transaction fees of approximately £2.0m, a portion of which are contingent on the issue of the proposed new shares. All costs which are directly attributable to the share issue will be recorded as a debit to equity.

 

 

 

 

Independent Review Report

 

To the Board of Huntsworth plc

 

Introduction

 

We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2013 which comprises the Consolidated Income Statement, the Consolidated Statement of Comprehensive Income, the Consolidated Balance Sheet, the Consolidated Statement of Cash Flows, the Consolidated Statement of Changes in Equity and the related notes 1 to 14. We have read the other information contained in the half yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

 

This report is made solely to the company in accordance with guidance contained in International Standard on Review Engagements 2410 (UK and Ireland) "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company, for our work, for this report, or for the conclusions we have formed. 

 

Directors' Responsibilities

 

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

As disclosed in note 1, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting", as adopted by the European Union.  

 

Our Responsibility

 

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.  

 

Scope of Review

 

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

 

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2013 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Conduct Authority.

 

Ernst & Young LLP

London

7 August 2013

 

 

Statement of Directors' Responsibilities

 

We confirm that to the best of our knowledge this interim report:

 

- has been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the European Union;

 

- includes a fair review of the information required by the Financial Conduct Authority's Disclosure and Transparency Rules ('DTR') 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

 

- includes a fair review of the information required by DTR 4.2.8R (disclosure of related party transactions and changes therein).

 

By order of the Board

 

Sally Withey

Group Chief Operating Officer and Group Finance Director

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFERTAIDIIV
Date   Source Headline
30th Apr 20203:30 pmRNSForm 8.3 - HNT LN
30th Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
30th Apr 20202:58 pmRNSHolding(s) in Company
30th Apr 20202:49 pmRNSCourt Sanction of the Scheme
30th Apr 20202:12 pmRNSHolding(s) in Company
30th Apr 202012:37 pmRNSHolding(s) in Company
30th Apr 202010:55 amRNSForm 8.5 (EPT/RI)
30th Apr 202010:05 amBUSForm 8.5 (EPT/NON-RI) - HUNTSWORTH PLC
30th Apr 20207:00 amRNSDISCLOSURE BY PERSON WITH INTERESTS IN SECURITIES
29th Apr 20204:28 pmRNSHolding(s) in Company
29th Apr 20203:30 pmRNSForm 8.3 - HNT LN
29th Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
29th Apr 202011:02 amRNSForm 8.5 (EPT/RI)
29th Apr 20209:41 amBUSForm 8.5 (EPT/NON-RI) - HUNTSWORTH PLC
29th Apr 20208:37 amRNSHolding(s) in Company
28th Apr 20204:53 pmRNSRule 2.9 Announcement
28th Apr 20203:30 pmRNSForm 8.3 - HNT LN
28th Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
28th Apr 202010:46 amRNSForm 8.5 (EPT/RI)
28th Apr 202010:35 amRNSForm 8.3 - HUNTSWORTH PLC
28th Apr 20209:21 amBUSForm 8.5 (EPT/NON-RI) - HUNTSWORTH PLC
27th Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
27th Apr 20209:50 amRNSHolding(s) in Company
27th Apr 20209:02 amBUSForm 8.5 (EPT/NON-RI) - Huntsworth plc
24th Apr 20205:30 pmRNSHuntsworth
24th Apr 20203:30 pmRNSForm 8.3 - HNT LN
24th Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
24th Apr 202011:04 amRNSForm 8.5 (EPT/RI)
24th Apr 20209:24 amBUSForm 8.5 (EPT/NON-RI) - HUNTSWORTH PLC
24th Apr 20209:21 amRNSForm 8.5 (EPT/RI) - Huntsworth plc
23rd Apr 20203:30 pmRNSForm 8.3 - HNT LN
23rd Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
23rd Apr 202012:18 pmRNSForm 8.3 - Huntsworth Plc
23rd Apr 202010:05 amBUSForm 8.5 (EPT/NON-RI) - Huntsworth plc
23rd Apr 20207:00 amRNSHolding(s) in Company
22nd Apr 20203:20 pmRNSForm 8.3 - Huntsworth plc
22nd Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
22nd Apr 202011:37 amRNSForm 8.3 - Huntsworth plc
22nd Apr 202010:44 amRNSForm 8.5 (EPT/RI)
22nd Apr 202010:33 amBUSFORM 8.5 (EPT/NON-RI) - HUNTSWORTH PLC
22nd Apr 20209:19 amRNSForm 8.5 (EPT/RI) - Huntsworth plc
22nd Apr 20208:53 amRNSHolding(s) in Company
21st Apr 20205:15 pmRNSForm 8.5 (EPT/RI)
21st Apr 20205:10 pmRNSForm 8.5 (EPT/RI)
21st Apr 20204:14 pmRNSOffer update: Antitrust clearance
21st Apr 20203:20 pmRNSForm 8.3 - Huntsworth plc
21st Apr 20203:15 pmBUSForm 8.3 - Huntsworth plc
21st Apr 20202:38 pmRNSForm 8.3 - Huntsworth plc
21st Apr 202012:13 pmRNSForm 8.3 - Huntsworth Plc
21st Apr 202011:53 amRNSForm 8.3 - Huntsworth Plc - AMENDMENT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.